Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Aytu amends follow-on

    Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-04-25 Type: Follow-on To be raised: TBD Shares: TBD Price prior: $0.69 Underwriters: Joseph Gunnar; Fordham Financial …

    Published on 5/2/2016
  • Intellia Therapeutics amends IPO

    Intellia Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics, Cancer Date announced: 2016-04-27 Type: IPO To be raised: Up to $90 million Shares: 5 million Price: $16-$18 Underwriters: Credit …

    Published on 5/2/2016
  • Oncobiologics amends IPO

    Oncobiologics Inc., Cranbury, N.J. Business: Antibodies, Autoimmune, Cancer Date announced: 2016-04-27 Type: IPO To be raised: Up to $65 million Shares: 5 million Price: $11-$13 Underwriters: Jefferies; Barclays Capital…

    Published on 5/2/2016
  • Spring Bank amends IPO

    Spring Bank Pharmaceuticals Inc., Milford, Mass. Business: Infectious, Pulmonary Date announced: 2016-04-26 Type: IPO To be raised: Up to $16.2 million Shares: 1.2 million Price: $12-$14 Underwriter: Dawson James …

    Published on 5/2/2016
  • Acerus Pharmaceuticals completes private placement

    Acerus Pharmaceuticals Corp. (TSX:ASP), Mississauga, Ontario Business: Drug delivery, Endocrine/Metabolic, Inflammation Date completed: 2016-04-27 Type: Private placement Raised: C$2.5 million ($2 million) Shares: 12.2 …

    Published on 5/2/2016
  • ADMA completes follow-on

    ADMA Biologics Inc. (NASDAQ:ADMA), Ramsey, N.J. Business: Hematology, Infectious Date completed: 2016-04-28 Type: Follow-on Raised: $12.3 million Shares: 1.9 million Price: $6.50 Shares after offering: 12.6 million …

    Published on 5/2/2016
  • Aradigm completes private placement of senior convertible notes

    Aradigm Corp. (NASDAQ:ARDM), Hayward, Calif. Business: Drug delivery, Pulmonary Date completed: 2016-04-22 Type: Private placement of senior convertible notes Raised: $23 million Shares outstanding prior: 14.8 million …

    Published on 5/2/2016
  • AtriCure completes debt financing

    AtriCure Inc. (NASDAQ:ATRC), West Chester, Ohio Business: Cardiovascular Date completed: 2016-04-25 Type: Debt financing Raised: $25 million Investor: Silicon Valley Bank Note: The five-year loan bears interest at the …

    Published on 5/2/2016
  • Durect completes follow-on

    Durect Corp. (NASDAQ:DRRX), Cupertino, Calif. Business: Drug delivery Date completed: 2016-04-26 Type: Follow-on Raised: $15 million Shares: 12 million Price: $1.25 Shares after offering: 134.7 million Underwriters: …

    Published on 5/2/2016
  • FLX completes venture financing

    FLX Bio Inc., South San Francisco, Calif. Business: Cancer Date completed: 2016-04-26 Type: Venture financing Raised: $50 million Investors: The Column Group; Topspin Fund; Kleiner Perkins Caufield & Byers; Celgene Corp…

    Published on 5/2/2016
  • Ignyta completes follow-on

    Ignyta Inc. (NASDAQ:RXDX), San Diego, Calif. Business: Cancer, Diagnostic Date completed: 2016-04-29 Type: Follow-on Raised: $50 million Shares: 8 million Price: $6.25 Shares after offering: 40.3 million Underwriters: …

    Published on 5/2/2016
  • Novacyt completes convertible bond financing

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2016-04-25 Type: Convertible bond financing Raised: EUR750,000 ($844,050) Shares outstanding prior: 10 million Investor…

    Published on 5/2/2016
  • Novacyt completes private placement

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2016-04-25 Type: Private placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 10 …

    Published on 5/2/2016
  • SalvaRx completes private placement of convertible notes

    SalvaRx Group plc (LSE:SALV), Ramsey, U.K. Business: Cancer Date completed: 2016-04-22 Type: Private placement of convertible notes Raised: $1 million Shares outstanding prior: 36.5 million Investor: Company directors …

    Published on 5/2/2016
  • Sienna Biopharmaceuticals completes venture financing

    Sienna Biopharmaceuticals Inc., Westlake Village, Calif. Business: Dermatology Date completed: 2016-04-28 Type: Venture financing Raised: $34 million Investors: Arch Venture Partners; Altitude Life Science Ventures; …

    Published on 5/2/2016
  • Theravance Biopharma completes follow-on

    Theravance Biopharma Inc. (NASDAQ:TBPH), South San Francisco, Calif. Business: Infectious, Neurology, Pulmonary Date completed: 2016-04-29 Type: Follow-on Raised: $100.1 million Shares: 4.8 million Price: $21 Shares …

    Published on 5/2/2016
  • Wilex completes rights offering

    Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Date completed: 2016-04-25 Type: Rights offering Raised: EUR4.1 million ($4.7 million) Shares: 2.2 million Price: EUR1.84 Shares after offering: 12.9 million …

    Published on 5/2/2016
  • Samsung BioLogics financial update

    Samsung BioLogics, Seoul, South Korea Business: Biomanufacturing, Supply/Service, Gene/Cell therapy Date announced: 2016-04-28 Note: Samsung BioLogics plans to file an IPO in South Korea this year. The company plans to …

    Published on 5/2/2016
  • The Column Group financial update

    The Column Group, San Francisco, Calif. Business: Finance Date announced: 2016-04-26 Note: The Column Group closed its third fund at $535 million, according to founder and Managing Partner Peter Svennilson. The firm …

    Published on 5/2/2016
  • UBS Group AG financial update

    UBS Group AG, Zurich, Switzerland Business: Finance Date announced: 2016-04-27 Note: UBS Group raised $471 million for the UBS Oncology Impact Fund, which will invest in early stage cancer treatments. MPM Capital is …

    Published on 5/2/2016
  • Champions Oncology proposes follow-on

    Champions Oncology Inc. (NASDAQ:CSBR), Hackensack, N.J. Business: Cancer Date announced: 2016-04-26 Type: Follow-on To be raised: Up to $5.8 million Shares: TBD Price prior: $4.05

    Published on 5/2/2016
  • Vernalis proposes placing

    Vernalis plc (LSE:VER), Winnersh, U.K. Business: Neurology, Cancer, Autoimmune Date announced: 2016-04-26 Type: Placing To be raised: Up to L40 million ($57.6 million) Shares: 80 million Price: 50p Shares outstanding …

    Published on 5/2/2016
  • Cancer Prevention Pharmaceuticals amends IPO

    Cancer Prevention Pharmaceuticals Inc., Tucson, Ariz. Business: Cancer Date announced: 2016-04-18 Type: IPO To be raised: Up to $26.9 million Shares: 1.9 million Price: $12-$14 Underwriter: Aegis Capital Overallotment: …

    Published on 4/25/2016
  • VistaGen amends follow-on

    VistaGen Therapeutics Inc. (OTCQB:VSTA), South San Francisco, Calif. Business: ADMET, Gene/Cell therapy, Neurology Date announced: 2016-04-15 Type: Follow-on To be raised: Up to $13.8 million Shares: TBD Price Prior: $8…

    Published on 4/25/2016
  • Amarantus BioScience completes private placement of senior convertible notes

    Amarantus BioScience Holdings Inc. (OTCQX:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Date completed: 2016-04-21 Type: Private placement of senior convertible notes Raised: $1.5 million Shares …

    Published on 4/25/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993